Matt Parker, P.h.D. ~ Principal Investigator

Dr Matt Parker is a behavioural neuroscientist specializing in neurodevelopmental and neuropsychiatric disorders. He studied psychology (BSc, MSc, PhD) at the University of Southampton, completing his PhD in 2008, where he characterised neurocognitive phenotypes associated with stereotypic behaviour in horses. He then moved to the Royal Veterinary College in Hertfordshire, where he worked as a Research Associate studying the behaviour and physiology of animals in intensive farming systems. He joined Queen Mary University of London in 2011, where he worked in Dr Caroline Brennan’s laboratory on an NC3Rs grant developing behavioural assays to facilitate forward genetic screens for identification of novel alleles linked to drug seeking and vulnerability to drug abuse. In 2014, Dr Parker was appointed lecturer in Cell Biology and Developmental Genetics. In 2015, he joined the University of Portsmouth as a Lecturer in Human Physiology.

James Clay ~ MRes Student (Pharmacology & Neuropsychiatric Disorder)

After recently graduating with a first in Human Physiology (BSc), James joined ParkerLab in 2017. As the awardee of the Human Physiology Progress Award at his graduation, he has already shown remarkable promise in his short research career. James is currently an MRes student interested in gaining a greater understanding into the  bio-psychology  that underpins neuropsychiatric disorders such as, drug addiction and relapse e.g. alcohol. James is currently looking to further his research career by actively looking for PhD opportunities in his field.  


Madeleine Cleal ~ Ph.D Student (Neuropharmacology and molecular neuroscience)

Madeleine's PhD is funded by the University of Portsmouth Bursary scheme, and is examining neural circuits underlying nicotine preference. She is using zebrafish as a model species.